Breast-conserving surgery without axillary lymph node surgery or radiotherapy is safe for HER2-positive and triple negative breast cancer patients over 70 years of age.
Ying ZhongYali XuYidong ZhouFeng MaoYan LinJinghong GuanSongjie ShenBo PanChangjun WangLi PengXin HuangYan LiXuefei WangQiang SunPublished in: Breast cancer research and treatment (2020)
BCSNR is not only suitable for elderly patients with luminal-type breast cancer but also for those with HER2-positive breast cancer and TNBC.
Keyphrases
- lymph node
- positive breast cancer
- minimally invasive
- neoadjuvant chemotherapy
- coronary artery bypass
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- early stage
- sentinel lymph node
- locally advanced
- prognostic factors
- middle aged
- atrial fibrillation
- squamous cell carcinoma
- percutaneous coronary intervention
- patient reported
- rectal cancer
- community dwelling